Aleem, Ahmed
Haque, Ali R.
Roloff, Gregory W.
Griffiths, Elizabeth A.
Article History
Accepted: 3 May 2021
First Online: 6 October 2021
Declarations
:
: Dr. Griffiths has received honoraria/advisory board payments from Alexion Pharmaceuticals, Celgene/BMS, AbbVie, and Novartis. EAG has also received institutional research funding from Genentech Inc., Appelis pharmaceuticals, Celldex Therapeutics, and Celgene/BMS. The other authors declare no conflicts of interest/competing interests.
: Not applicable.
: Not applicable.
: Not applicable.
: This article does not contain any studies with human or animal subjects performed by any of the authors.